ArticleNature medicine2025

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

Gusztav Milotay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.